AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE
According to the World Health Organization, anxiety and depressive disorders will be the second leading cause of disability by 2020. The review is devoted to the modern concepts of the pathophysiology of depression in patients with ischemic heart disease (IHD) and to the possibilities of antidepre...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2017-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1425 |
| _version_ | 1797232233052897280 |
|---|---|
| author | N. Yu. Shimohina M. M. Petrova A. A. Savchenko M. S. Chernyaeva |
| author_facet | N. Yu. Shimohina M. M. Petrova A. A. Savchenko M. S. Chernyaeva |
| author_sort | N. Yu. Shimohina |
| collection | DOAJ |
| description | According to the World Health Organization, anxiety and depressive disorders will be the second leading cause of disability by 2020. The review is devoted to the modern concepts of the pathophysiology of depression in patients with ischemic heart disease (IHD) and to the possibilities of antidepressant therapy. The paper presents analysis of international and domestic researches devoted to efficiency and safety of agomelatine in patients both with chronic IHD and with unstable angina and acute myocardial infarction. The review also discusses different points of view, indicating the need for further studies to evaluate the short and long term effects of antidepressants in patients with IHD in combination with anxiety and depressive disorders. |
| first_indexed | 2024-03-08T14:02:06Z |
| format | Article |
| id | doaj.art-79dad47afa68407a9a2ced949390fdc5 |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-04-24T15:57:01Z |
| publishDate | 2017-03-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-79dad47afa68407a9a2ced949390fdc52024-04-01T07:43:34ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532017-03-0113111612310.20996/1819-6446-2017-13-1-116-1231314AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASEN. Yu. Shimohina0M. M. Petrova1A. A. Savchenko2M. S. Chernyaeva3Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky; Krasnoyarsk Regional Inter-District Clinical Emergency Hospital named after N.S. KarpovichKrasnoyarsk State Medical University named after Professor V.F. Voyno-YasenetskyKrasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky; Research Institute of Medical Problems of the North, Siberian Branch of the Russian Academy of SciencesKrasnoyarsk State Medical University named after Professor V.F. Voyno-YasenetskyAccording to the World Health Organization, anxiety and depressive disorders will be the second leading cause of disability by 2020. The review is devoted to the modern concepts of the pathophysiology of depression in patients with ischemic heart disease (IHD) and to the possibilities of antidepressant therapy. The paper presents analysis of international and domestic researches devoted to efficiency and safety of agomelatine in patients both with chronic IHD and with unstable angina and acute myocardial infarction. The review also discusses different points of view, indicating the need for further studies to evaluate the short and long term effects of antidepressants in patients with IHD in combination with anxiety and depressive disorders.https://www.rpcardio.online/jour/article/view/1425anxietydepressionischemic heart diseaseantidepressantsagomelatine |
| spellingShingle | N. Yu. Shimohina M. M. Petrova A. A. Savchenko M. S. Chernyaeva AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE Рациональная фармакотерапия в кардиологии anxiety depression ischemic heart disease antidepressants agomelatine |
| title | AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE |
| title_full | AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE |
| title_fullStr | AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE |
| title_full_unstemmed | AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE |
| title_short | AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE |
| title_sort | agomelatine in the treatment of anxiety and depressive disorders in patients with ischemic heart disease |
| topic | anxiety depression ischemic heart disease antidepressants agomelatine |
| url | https://www.rpcardio.online/jour/article/view/1425 |
| work_keys_str_mv | AT nyushimohina agomelatineinthetreatmentofanxietyanddepressivedisordersinpatientswithischemicheartdisease AT mmpetrova agomelatineinthetreatmentofanxietyanddepressivedisordersinpatientswithischemicheartdisease AT aasavchenko agomelatineinthetreatmentofanxietyanddepressivedisordersinpatientswithischemicheartdisease AT mschernyaeva agomelatineinthetreatmentofanxietyanddepressivedisordersinpatientswithischemicheartdisease |